Advertisement

IART

Integra LifeSciences Holdings Corporation

Healthcare · USD

Set alert

Price alert · IART

All alert types
12.75 USD -0.08 -0.62%
As of Oct 30, 2026 Extended hours 12.75 0.00%
Bid
12.75 × 2
Ask
12.76 × 2
12.34 Day range 12.85
8.90 52-week range 19.85
YTD
+2.66%
1 year
+7.96%
Open
12.74
Prev close
12.83
Mkt cap
991.60M
Vol
1.04M
Avg vol
948.94K
EPS
0.17
P/E
75.00
Div yield
0.00%
More statistics
Low
12.34
High
12.85
Forward P/E
5.29
Beta
1.21
Short ratio
8.11
Inst. own
98.42%
Dividend
0.00
Ex-div date
Earnings
Oct 21, 2026
50-d avg
15.76
200-d avg
14.09
1y target
18.00

5D chart

Chart tools
Interval
IART five-day price chart11.711.912.112.312.4Oct 23Oct 26Oct 27Oct 28Oct 29

Key statistics

Market cap
1.04B
Enterprise value
2.82B
Trailing P/E
0.00
Forward P/E
5.29
PEG ratio
0.67
Price / sales
0.63
Price / book
0.99
EPS (TTM)
-0.09
Beta
1.21
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-0.44%
Revenue (TTM)
1.65B
Revenue growth
0.80%
Free cash flow
94.40M
Total cash
274.08M
Total debt
2.05B
Return on equity
-0.70%
Shares outstanding
77.77M
Short % of float
12.88%
50-day average
15.76
200-day average
14.09

Analyst view

Consensus: hold

Hold
Price target (mean) 18.00 +41.2% upside
Target (low)
14.00
Target (mean)
18.00
Target (high)
27.00
Ratings (0m) 12 3 buy · 7 hold · 2 sell
  • Strong buy1
  • Buy2
  • Hold7
  • Sell0
  • Strong sell2

Next earnings

Oct 21, 2026

Expected Oct 21, 2026. Consensus EPS estimate 0.55915.

Earnings history

Financials — quick view

All financials
IART Revenue — quarterly 411.18M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
IART Net income — quarterly 14.85M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
IART EPS — quarterly 0.19
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

IART recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 21, 2026Sep 30, 20260.557———
Jul 29, 2026Jun 30, 20260.48050.56+0.08+16.55%
May 5, 2026Mar 31, 20260.410.54+0.13+31.71%
Feb 26, 2026Dec 31, 20250.790.83+0.04+5.06%
Oct 30, 2025Sep 30, 20250.430.54+0.11+25.58%
Jul 31, 2025Jun 30, 20250.430.45+0.02+4.65%

Upgrades / downgrades

IART analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026Truist SecuritiesmainHoldHold
Oct 5, 2026CitigroupmainNeutralNeutral
Oct 5, 2026BMO CapitalmainMarket PerformMarket Perform
Jul 30, 2026Wells FargomainEqual-WeightEqual-Weight
Jul 28, 2026UBSinit—Neutral
Jul 16, 2026Truist SecuritiesmainHoldHold

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on IART — it syncs with the Stock Master app.

Insider holders

IART insider holders
InsiderRelationLatest transactionDateShares held
BRADLEY KEITHDirectorStock Award(Grant)May 8, 202589,136
CLAY SHAUNDRADirectorStock Award(Grant)May 8, 202541,515
DAVIS ROBERT T JROfficerStock Award(Grant)Mar 10, 202575,561
ESSIG STUART PH.D.Officer and DirectorStock Award(Grant)May 8, 20251,785,270
GRAVES JEFFREY A.DirectorPurchaseNov 4, 202541,086
HILL BARBARA BENTONDirectorStock Award(Grant)May 6, 2026187,541

Institution ownership

IART institution ownership
Holder% heldSharesValueReported
Blackrock Inc.13.74%10,684,103142.42MJun 29, 2026
Rubric Capital Management LP9.97%7,753,934103.36MJun 29, 2026
Invesco Ltd.4.82%3,749,36749.98MJun 29, 2026
Vanguard Portfolio Management LLC4.81%3,743,09349.90MJun 29, 2026
Morgan Stanley4.62%3,593,07947.90MJun 29, 2026
Fuller & Thaler Asset Management Inc.4.42%3,436,00645.80MJun 29, 2026

Fund ownership

IART fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.24%4,072,32054.28MAug 30, 2026
AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund4.36%3,389,02445.18MJul 30, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.3.63%2,822,34337.62MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.71%2,108,29528.10MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.26%1,754,19923.38MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.95%1,515,00220.19MJun 29, 2026
Advertisement